AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 19106242 — intervention group
Group type: EXPERIMENTAL
Intervention: Phytase + NaFeEDTA + ascorbic acid
Number of subjects: 101
Study 19106242 — intervention group
Group type: COMPARATOR
Intervention: FeSO4 without enhancers
Number of subjects: 101
Study 19106242 — intervention group
Group type: EXPERIMENTAL
Intervention: Phytase + NaFeEDTA
Number of subjects: 101
Study 19106242 — intervention group
Group type: EXPERIMENTAL
Intervention: Phytase + ascorbic acid + NaFeEDTA
Number of subjects: 101
Study 19106242 — intervention group
Group type: EXPERIMENTAL
Intervention: L-alpha-glycerophosphocholine
Number of subjects: 101
Study 19106242 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium with ascorbic acid + NaFeEDTA
Number of subjects: 101
Study 17302055 — intervention group
Group type: EXPERIMENTAL
Intervention: Xiongshao Capsule (XC)
Number of subjects: 335
Study 17302055 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 335
Study 15118486 — intervention group
Group type: EXPERIMENTAL
Intervention: Donepezil (acetylcholinesterase inhibitor)
Number of subjects: 0
Study 11561117 — intervention group
Group type: EXPERIMENTAL
Intervention: Joint protection arthritis education programme
Number of subjects: 127
Study 11561117 — intervention group
Group type: COMPARATOR
Intervention: Standard arthritis education programme
Number of subjects: 127
Study 9756169 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral dexamethasone 2 mg/m2 during radiotherapy
Number of subjects: 32
Study 9756169 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral dexamethasone 4 mg/m2 during radiotherapy
Number of subjects: 32
Study 8161291 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-tryptophan diet (160 mg/d) followed by a drink of 15 amino acids
Number of subjects: 15
Study 8161291 — intervention group
Group type: COMPARATOR
Intervention: Control (tryptophan-supplemented testing)
Number of subjects: 15
Study 3825986 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutrient-based method (Diet Guide)
Number of subjects: 83
Study 3825986 — intervention group
Group type: COMPARATOR
Intervention: Food-group method (Exchange Lists)
Number of subjects: 83
Study 3825986 — intervention group
Group type: EXPERIMENTAL
Intervention: Both methods
Number of subjects: 83
Study 31843639 — intervention group
Group type: EXPERIMENTAL
Intervention: SleepWell24 smartphone application
Number of subjects: 0
Study 31843639 — intervention group
Group type: COMPARATOR
Intervention: Usual care control condition
Number of subjects: 0
Study 31692870 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin (20 mg/d)
Number of subjects: 32
Study 31692870 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study 27995073 — intervention group
Group type: EXPERIMENTAL
Intervention: ADHD childhood diagnosis with cannabis use (n=23)
Number of subjects: 75
Study 27995073 — intervention group
Group type: EXPERIMENTAL
Intervention: ADHD childhood diagnosis without cannabis use (n=22)
Number of subjects: 75
Study 27995073 — intervention group
Group type: EXPERIMENTAL
Intervention: Cannabis use without ADHD (n=15)
Number of subjects: 75
Study 27995073 — intervention group
Group type: COMPARATOR
Intervention: Non-users without ADHD (n=15)
Number of subjects: 75
Study 26423732 — intervention group
Group type: EXPERIMENTAL
Intervention: Garlic-containing meal (100 g white bread, 15 g butter, and 5 g raw, crushed garlic)
Number of subjects: 17
Study 26423732 — intervention group
Group type: COMPARATOR
Intervention: Garlic-free control meal (100 g white bread and 15 g butter)
Number of subjects: 17
Study 26423732 — intervention group
Group type: EXPERIMENTAL
Intervention: Purified garlic extract (0.5 μL/mL) in Mono Mac 6 cells
Number of subjects: 17
Study 26423732 — intervention group
Group type: EXPERIMENTAL
Intervention: Garlic treatment
Number of subjects: 17
Study 21940462 — intervention group
Group type: EXPERIMENTAL
Intervention: experimental explicit, systematic, code‐based program
Number of subjects: 206
Study 21940462 — intervention group
Group type: COMPARATOR
Intervention: typical kindergarten reading intervention
Number of subjects: 206
Study 21930410 — intervention group
Group type: EXPERIMENTAL
Intervention: Skin traction
Number of subjects: 40
Study 21930410 — intervention group
Group type: COMPARATOR
Intervention: No skin traction (Control)
Number of subjects: 40
Study 18757089 — intervention group
Group type: EXPERIMENTAL
Intervention: Rosuvastatin 10 mg daily
Number of subjects: 4574
Study 18757089 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4574
Study 16023823 — intervention group
Group type: EXPERIMENTAL
Intervention: Group support program
Number of subjects: 257
Study 16023823 — intervention group
Group type: EXPERIMENTAL
Intervention: Home visiting program
Number of subjects: 257
Study 12952518 — intervention group
Group type: EXPERIMENTAL
Intervention: Soft tissue massage (6 treatments)
Number of subjects: 29
Study 12952518 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment, waiting list)
Number of subjects: 29
Study 10663354 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium supplementation
Number of subjects: 0
Study 10663354 — intervention group
Group type: EXPERIMENTAL
Intervention: Purposeful load‐bearing exercise
Number of subjects: 0
Study 10663354 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral contraceptives
Number of subjects: 0
Study 10663354 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation
Number of subjects: 0
Study 10663354 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate intakes of alcohol and caffeine
Number of subjects: 0
Study 10663354 — intervention group
Group type: EXPERIMENTAL
Intervention: Appropriate treatment of endometriosis
Number of subjects: 0
Study 9063757 — intervention group
Group type: EXPERIMENTAL
Intervention: Diflunisal (500 mg)
Number of subjects: 104
Study 9063757 — intervention group
Group type: COMPARATOR
Intervention: Paracetamol (500 mg)
Number of subjects: 104
Study 1648849 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium selenite therapy (500 micrograms daily)
Number of subjects: 8
Study 1648849 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified treatment)
Number of subjects: 8
Study 1648849 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium selenite therapy
Number of subjects: 8
Study 6356320 — intervention group
Group type: EXPERIMENTAL
Intervention: sucralfate, 4 g daily
Number of subjects: 121
Study 6356320 — intervention group
Group type: COMPARATOR
Intervention: cimetidine, 1 g daily
Number of subjects: 121
Study 30921489 — intervention group
Group type: EXPERIMENTAL
Intervention: Dried urine spots (DUS) screening method
Number of subjects: 49
Study 30921489 — intervention group
Group type: EXPERIMENTAL
Intervention: Dried urine spots (DUS)
Number of subjects: 49
Study 29018989 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous treadmill exercise (65% maximal oxygen consumption)
Number of subjects: 11
Study 29018989 — intervention group
Group type: COMPARATOR
Intervention: Quiet rest (REST)
Number of subjects: 11
Study 26135813 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined PFS and local vaginal estrogen (Group C)
Number of subjects: 315
Study 26135813 — intervention group
Group type: EXPERIMENTAL
Intervention: Pelvic floor electrical stimulation (PFS) (Group A)
Number of subjects: 315
Study 26135813 — intervention group
Group type: COMPARATOR
Intervention: Local vaginal estrogen (Group B)
Number of subjects: 315
Study 25567460 — intervention group
Group type: EXPERIMENTAL
Intervention: FSP regimen plus a supplement of 'Parma pap' (Group 2)
Number of subjects: 332
Study 25567460 — intervention group
Group type: COMPARATOR
Intervention: FSP portions only (Group 1)
Number of subjects: 332
Study 25567460 — intervention group
Group type: EXPERIMENTAL
Intervention: 'Parma pap' given to twenty-one malnourished children at Xaverian Mission
Number of subjects: 332
Study 21873922 — intervention group
Group type: EXPERIMENTAL
Intervention: Office-based vergence/accommodative therapy with home reinforcement (OBVAT)
Number of subjects: 221
Study 21873922 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based computer vergence/accommodative therapy (HBCVAT+)
Number of subjects: 221
Study 21873922 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based pencil push-up therapy (HBPP)
Number of subjects: 221
Study 21873922 — intervention group
Group type: COMPARATOR
Intervention: Office-based placebo therapy (OBPT)
Number of subjects: 221
Study 20396714 — intervention group
Group type: EXPERIMENTAL
Intervention: artrofoon for 12 months in addition to basis therapy
Number of subjects: 50
Study 20396714 — intervention group
Group type: COMPARATOR
Intervention: basis therapy
Number of subjects: 50
Study 17581200 — intervention group
Group type: EXPERIMENTAL
Intervention: High-sulphite wine
Number of subjects: 8
Study 17581200 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-sulphite wine
Number of subjects: 8
Study 17581200 — intervention group
Group type: COMPARATOR
Intervention: Placebo challenge
Number of subjects: 8
Study 15319721 — intervention group
Group type: EXPERIMENTAL
Intervention: Prerequisite Curriculum (PRC) e-learning system
Number of subjects: 138
Study 15319721 — intervention group
Group type: COMPARATOR
Intervention: Control group (traditional texts and journals)
Number of subjects: 138
Study 15319721 — intervention group
Group type: EXPERIMENTAL
Intervention: PRC e-learning system
Number of subjects: 138
Study 11306238 — intervention group
Group type: EXPERIMENTAL
Intervention: Screening for chlamydial infection in nonpregnant women
Number of subjects: 0
Study 11306238 — intervention group
Group type: EXPERIMENTAL
Intervention: Screening for chlamydial infection in pregnant women
Number of subjects: 0
Study 11306238 — intervention group
Group type: EXPERIMENTAL
Intervention: DNA amplification tests using endocervical swabs in women
Number of subjects: 0
Study 11306238 — intervention group
Group type: EXPERIMENTAL
Intervention: DNA amplification tests using urethral swabs in men
Number of subjects: 0
Study 11306238 — intervention group
Group type: EXPERIMENTAL
Intervention: First-void urine specimens from men and women
Number of subjects: 0
Study 11306238 — intervention group
Group type: COMPARATOR
Intervention: Screening for chlamydial infection in men
Number of subjects: 0
Study 9566667 — intervention group
Group type: EXPERIMENTAL
Intervention: Uncooked vegan diet rich in lactobacilli
Number of subjects: 0
Study 9566667 — intervention group
Group type: COMPARATOR
Intervention: Control group (omnivorous diet)
Number of subjects: 0
Study 8063620 — intervention group
Group type: EXPERIMENTAL
Intervention: Liposomal adriamycin (Lipo‐ADR)
Number of subjects: 52
Study 8063620 — intervention group
Group type: COMPARATOR
Intervention: Free adriamycin (F‐ADR)
Number of subjects: 52
Study 2927860 — intervention group
Group type: EXPERIMENTAL
Intervention: Amnioinfusion with 1000 mL normal saline initially and every 6 hours until delivery
Number of subjects: 85
Study 2927860 — intervention group
Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 85
Study 5039550 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenfluramine
Number of subjects: 39
Study 5039550 — intervention group
Group type: COMPARATOR
Intervention: Phentermine
Number of subjects: 39
Study 31290278 — intervention group
Group type: EXPERIMENTAL
Intervention: Parenting program
Number of subjects: 77
Study 31290278 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment
Number of subjects: 77
Study 26918815 — intervention group
Group type: EXPERIMENTAL
Intervention: Group-based dance exergaming (36 hours over 3 months)
Number of subjects: 41
Study 26918815 — intervention group
Group type: COMPARATOR
Intervention: Self-directed care control condition
Number of subjects: 41
Study 26364765 — intervention group
Group type: EXPERIMENTAL
Intervention: Bepotastine besilate (10 mg orally twice daily for 2 weeks)
Number of subjects: 473
Study 26364765 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 473
Study 22789310 — intervention group
Group type: EXPERIMENTAL
Intervention: 20min post-warm-up recovery
Number of subjects: 8
Study 22789310 — intervention group
Group type: COMPARATOR
Intervention: 45min post-warm-up recovery
Number of subjects: 8
Study 20697755 — intervention group
Group type: EXPERIMENTAL
Intervention: Sealed with polyurethane-dimethacrylate foil using bonding
Number of subjects: 50
Study 20697755 — intervention group
Group type: COMPARATOR
Intervention: Oral home care (Control)
Number of subjects: 50
Study 18425006 — intervention group
Group type: EXPERIMENTAL
Intervention: Complete resection (n = 122)
Number of subjects: 243
Study 18425006 — intervention group
Group type: COMPARATOR
Intervention: Incomplete resection (n = 121)
Number of subjects: 243
Study 18425006 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with residual tumor
Number of subjects: 243
Study 18425006 — intervention group
Group type: COMPARATOR
Intervention: Patients without residual tumor
Number of subjects: 243
Study 16494704 — intervention group
Group type: EXPERIMENTAL
Intervention: Early discharge at > or = 1650 g
Number of subjects: 120
Study 16494704 — intervention group
Group type: COMPARATOR
Intervention: Routine discharge at > or = 1800 g
Number of subjects: 120
Study 12970329 — intervention group
Group type: EXPERIMENTAL
Intervention: Valsartan 160 mg daily
Number of subjects: 32
Study 12970329 — intervention group
Group type: COMPARATOR
Intervention: Simvastatin 80 mg daily
Number of subjects: 32
Study 12970329 — intervention group
Group type: COMPARATOR
Intervention: Quinapril 40 mg daily
Number of subjects: 32
Study 12970329 — intervention group
Group type: COMPARATOR
Intervention: No treatment (control group)
Number of subjects: 32
Study 10723240 — intervention group
Group type: EXPERIMENTAL
Intervention: KW‐2228 (rhG‐CSF)
Number of subjects: 98
Study 10723240 — intervention group
Group type: COMPARATOR
Intervention: Untreated group
Number of subjects: 98
Study 9370111 — intervention group
Group type: EXPERIMENTAL
Intervention: Etomoxir (100 mg/day for 3 days)
Number of subjects: 12
Study 1283591 — intervention group
Group type: EXPERIMENTAL
Intervention: Verapamil 240 mg/day for 14 days
Number of subjects: 14
Study 1283591 — intervention group
Group type: COMPARATOR
Intervention: High sodium intake (11 g/day)
Number of subjects: 14
Study 1283591 — intervention group
Group type: COMPARATOR
Intervention: Low sodium intake (4 g/day)
Number of subjects: 14
Study 1283591 — intervention group
Group type: EXPERIMENTAL
Intervention: Verapamil treatment
Number of subjects: 14
Study 4026927 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulfadiazine (4 mg/kg twice daily, initial dose 8 mg/kg)
Number of subjects: 16
Study 4026927 — intervention group
Group type: COMPARATOR
Intervention: Sulfafurazole (50 mg/kg four times a day)
Number of subjects: 16
Study 4026927 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulfadiazine
Number of subjects: 16
Study 4026927 — intervention group
Group type: COMPARATOR
Intervention: Sulfafurazole
Number of subjects: 16
Study 31420812 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet-rich plasma (PRP) injection
Number of subjects: 98
Study 31420812 — intervention group
Group type: COMPARATOR
Intervention: Corticosteroid injection
Number of subjects: 98
Study 29976165 — intervention group
Group type: EXPERIMENTAL
Intervention: Active air purifier (Atmosphere; Amway China)
Number of subjects: 60
Study 29976165 — intervention group
Group type: COMPARATOR
Intervention: Inactive air purifier (placebo)
Number of subjects: 60
Study 27909165 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose psilocybin (22 or 30 mg/70 kg)
Number of subjects: 51
Study 27909165 — intervention group
Group type: COMPARATOR
Intervention: Placebo-like dose (1 or 3 mg/70 kg)
Number of subjects: 51
Study 25141203 — intervention group
Group type: EXPERIMENTAL
Intervention: Papacarie™ gel for chemo‐mechanical caries removal
Number of subjects: 20
Study 25141203 — intervention group
Group type: COMPARATOR
Intervention: Conventional caries removal with a low‐speed bur
Number of subjects: 20
Study 22852802 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based smoking cessation program (Decide2Quit)
Number of subjects: 1488
Study 19913143 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous LNG 90 mcg/EE 20 mcg
Number of subjects: 641
Study 19913143 — intervention group
Group type: COMPARATOR
Intervention: Cyclic LNG 100 mcg/EE 20 mcg
Number of subjects: 641
Study 17149671 — intervention group
Group type: EXPERIMENTAL
Intervention: Provider-delivered, individualized, stage-based interventions; details on dosage and duration not available.
Number of subjects: 0
Study 17149671 — intervention group
Group type: EXPERIMENTAL
Intervention: Audio-computerized-assisted, self-interviewing systems; details on dosage and duration not available.
Number of subjects: 0
Study 15221293 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta-blocker therapy
Number of subjects: 53
Study 12670085 — intervention group
Group type: EXPERIMENTAL
Intervention: SRP + MPTS (scaling and root-planing followed by one dose per pocket of minocycline microspheres, 1 mg)
Number of subjects: 0
Study 12670085 — intervention group
Group type: EXPERIMENTAL
Intervention: SRP + MPTS
Number of subjects: 0
Study 12670085 — intervention group
Group type: COMPARATOR
Intervention: SRP alone
Number of subjects: 0
Study 12670085 — intervention group
Group type: COMPARATOR
Intervention: MPTS alone
Number of subjects: 0
Study 12670085 — intervention group
Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 0
Study 9825187 — intervention group
Group type: EXPERIMENTAL
Intervention: verapamil
Number of subjects: 1775
Study 9825187 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 1775
Study 8009754 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish oil (2.7 g n‐3 fatty acids per day)
Number of subjects: 533
Study 8009754 — intervention group
Group type: COMPARATOR
Intervention: Olive oil (4 1‐g capsules per day)
Number of subjects: 533
Study 8009754 — intervention group
Group type: COMPARATOR
Intervention: No oil supplementation
Number of subjects: 533
Study 2691476 — intervention group
Group type: EXPERIMENTAL
Intervention: ticarcillin/clavulanate (3.1 g every 4 h)
Number of subjects: 112
Study 2691476 — intervention group
Group type: COMPARATOR
Intervention: gentamicin plus clindamycin (900 mg every 8 h)
Number of subjects: 112
Study 1091001 — intervention group
Group type: EXPERIMENTAL
Intervention: Colestipol hydrochloride (5 gm three times daily)
Number of subjects: 60
Study 1091001 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 1091001 — intervention group
Group type: EXPERIMENTAL
Intervention: Colestipol hydrochloride
Number of subjects: 60
Study 30455329 — intervention group
Group type: EXPERIMENTAL
Intervention: Incessant increase OGTT glucose response curve
Number of subjects: 662
Study 30455329 — intervention group
Group type: COMPARATOR
Intervention: Monophasic OGTT glucose response curve
Number of subjects: 662
Study 30455329 — intervention group
Group type: COMPARATOR
Intervention: Biphasic OGTT glucose response curve
Number of subjects: 662
Study 28039643 — intervention group
Group type: EXPERIMENTAL
Intervention: Pressure-Controlled Ventilation (PCV)
Number of subjects: 26
Study 28039643 — intervention group
Group type: COMPARATOR
Intervention: Volume-Controlled Ventilation (VCV)
Number of subjects: 26
Study 25504487 — intervention group
Group type: EXPERIMENTAL
Intervention: Education and daily exercise (4 spinal movements for daily practice)
Number of subjects: 708
Study 25504487 — intervention group
Group type: COMPARATOR
Intervention: Education alone (control group)
Number of subjects: 708
Study 25504487 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (intervention and control)
Number of subjects: 708
Study 23779114 — intervention group
Group type: EXPERIMENTAL
Intervention: High diet (45% of energy from fat, >25% saturated fat, 35%-40% from carbohydrates with a mean glycemic index >70, and 15%-20% from protein)
Number of subjects: 47
Study 23779114 — intervention group
Group type: COMPARATOR
Intervention: Low diet (25% of energy from fat, <7% saturated fat, 55%-60% from carbohydrates with a mean glycemic index <55, and 15%-20% from protein)
Number of subjects: 47
Study 22239052 — intervention group
Group type: EXPERIMENTAL
Intervention: Ambroxol (B group)
Number of subjects: 97
Study 22239052 — intervention group
Group type: EXPERIMENTAL
Intervention: Eucalyptol-limonene-pinene enteric soft capsule (C group)
Number of subjects: 97
Study 22239052 — intervention group
Group type: COMPARATOR
Intervention: Control group (A group)
Number of subjects: 97
Study 19845513 — intervention group
Group type: EXPERIMENTAL
Intervention: Fixed Atenolol Amlodipine Combination (FAAC) monotherapy
Number of subjects: 570
Study 19845513 — intervention group
Group type: EXPERIMENTAL
Intervention: Fixed Atenolol Amlodipine Combination (FAAC) in combination therapy
Number of subjects: 570
Study 19845513 — intervention group
Group type: EXPERIMENTAL
Intervention: Fixed Atenolol Amlodipine Combination (FAAC)
Number of subjects: 570
Study 16974191 — intervention group
Group type: EXPERIMENTAL
Intervention: DHEA (200 mg/d)
Number of subjects: 55
Study 16974191 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 55
Study 15153724 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg of mitoxantrone (6 weekly and 20 fortnightly instillations)
Number of subjects: 208
Study 15153724 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg of mitoxantrone (3 fortnightly and 10 monthly instillations)
Number of subjects: 208
Study 15153724 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 MU of IFNalpha‐2b (8 weekly, 8 fortnightly and 6 monthly instillations)
Number of subjects: 208
Study 15153724 — intervention group
Group type: COMPARATOR
Intervention: No further therapy (control group)
Number of subjects: 208
Study 11420318 — intervention group
Group type: EXPERIMENTAL
Intervention: Early sodium supplementation (4 mmol/kg/day starting from 24 hours after birth)
Number of subjects: 0
Study 11420318 — intervention group
Group type: COMPARATOR
Intervention: Delayed sodium supplementation (4 mmol/kg/day starting when a weight loss of 6% of birth weight was achieved)
Number of subjects: 0
Study 9652560 — intervention group
Group type: EXPERIMENTAL
Intervention: rhIGF‐I 40 microg/kg daily
Number of subjects: 53
Study 9652560 — intervention group
Group type: EXPERIMENTAL
Intervention: rhIGF‐I 20 microg/kg daily
Number of subjects: 53
Study 9652560 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 53
Study 8437014 — intervention group
Group type: EXPERIMENTAL
Intervention: Capgras delusion group
Number of subjects: 6
Study 8437014 — intervention group
Group type: COMPARATOR
Intervention: Control group (paranoid schizophrenics)
Number of subjects: 6
Study 3317057 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-ASA at a dosage of 4.8 g per day
Number of subjects: 87
Study 3317057 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-ASA at a dosage of 1.6 g per day
Number of subjects: 87
Study 3317057 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 87